Browsing Tag

Psoriasis

6 posts
Psoriasis Affects an Estimated 3% of US Adults thumbnail

Psoriasis Affects an Estimated 3% of US Adults

Please enable cookies. Error 1005 Ray ID: 903114a47f74f37f • 2025-01-16 21:08:24 UTC What happened? The owner of this website (www.medscape.com) has banned the autonomous system number (ASN) your IP address is in (47583) from accessing this website. Was this page helpful? Thank you for your feedback! Cloudflare Ray ID: 903114a47f74f37f • Your IP: 185.124.111.116 •
Read More
Could Psoriasis Treatment Be This Simple? thumbnail

Could Psoriasis Treatment Be This Simple?

Dermatology > Psoriasis — Off-the-shelf drug reduces skin inflammation in animal models and human cell culture by John Gever, Contributing Writer, MedPage Today December 11, 2024 A derivative of the diuretic drug amiloride (Midamor) blocked key inflammatory pathways in mouse models of psoriasis, including xenografts of psoriatic human skin, as well as in cultured patient
Read More
Link Between Psoriasis, Heart Disease Tracks to Coronary Microvascular Dysfunction thumbnail

Link Between Psoriasis, Heart Disease Tracks to Coronary Microvascular Dysfunction

Dermatology > Psoriasis — Lower coronary flow reserve associated with severity, duration of psoriasis by Charles Bankhead, Senior Editor, MedPage Today September 20, 2023 Almost a third of patients with severe psoriasis had echocardiographic evidence of asymptomatic coronary microvascular dysfunction (CMD), a prospective study showed. Doppler echocardiography showed that 31.5% of 448 patients with psoriasis
Read More
Biologic for Rare Form of Psoriasis Under FDA Priority Review thumbnail

Biologic for Rare Form of Psoriasis Under FDA Priority Review

The Food and Drug Administration has accepted a Biologics License Application for spesolimab, a selective antibody that blocks interleukin-36 receptors, for the treatment of flares in patients with generalized pustular psoriasis, according to a statement from manufacturer Boehringer Ingelheim. The FDA also granted Priority Review to spesolimab. Priority Review is a designation granted to medications that would offer…
Read More
What People With Psoriasis Can Learn From the Pandemic thumbnail

What People With Psoriasis Can Learn From the Pandemic

For over a year we've all been facing an extremely stressful situation. Many conditions are exacerbated by stress, and psoriasis is no exception. In fact, it's likely that many people were diagnosed with psoriasis for the first time during the pandemic. To make things worse, dealing with psoriasis can in turn increase stress, especially when…
Read More
Dogs React to Psoriasis, Other Conditions thumbnail

Dogs React to Psoriasis, Other Conditions

Whenever Russell Hartstein's psoriasis flares up, count on his 6-year-old German shepherd, Koa, to try to lick the dry patches on his elbows.“He always seems attuned and curious about people, is very affectionate and observant,” says Hartstein, who is tuned into such things himself as a certified dog trainer.Harstein has had psoriasis since childhood. Koa isn't…
Read More
Index Of News